3 US Healthcare Stocks Turning Bullish
Three US Healthcare stocks, Align Tech, Edwards Lifesciences, and Gilead Sciences, recently flipped bullish on the Altra Score, signaling potential
- Visit the stock pages: ALGN, EW, GILD
- Sector XLV , which ranks #3 for Relative Strength (Altra Sector score of 71.0 with bullish regime.)
The US market is showing signs of improving breadth, and within this context, the Healthcare sector has recently drawn attention with a cluster of momentum shifts. The Altra Market score, which assesses overall market breadth by tracking the percentage of stocks trading above key Exponential Moving Averages (EMAs), currently stands at an 'Improving' 66.3, indicating a constructive environment. Meanwhile, the Healthcare sector (with an Altra Sector score of 71.0) is ranked 3rd and identified as a 'Confirmed leader, accelerating,' boasting a Relative Strength Index (RS RSI) of 55.0.
This backdrop sets the stage for several individual stocks within the sector to exhibit notable momentum changes. The Altra Score is a momentum metric from 0 to 100 for individual stocks, derived from the alignment of EMAs and the trend of the Relative Strength Index (RSI) across multiple timeframes – daily, weekly, and monthly. A higher score suggests more bullish momentum. Here's a look at three US Healthcare stocks that have recently moved into bullish territory.
Align Technology (ALGN)
Align Technology, known for its Invisalign clear aligners, experienced a significant shift in its Altra Score on August 3, 2026, moving from 33.9 (Bearish) to 64.0 (Bullish). This marked a decisive change in its momentum profile. The stock's price action now places it above its key EMAs, a classic technical sign of strength. Further supporting this bullish turn, ALGN recorded a bullish Weekly EMA Crossover earlier in the year, on January 9, 2026. While its daily RSI sits at 48.38, just shy of the 50 neutral line, its weekly RSI at 50.32 and monthly RSI at 51.04 suggest a longer-term trend that has begun to tilt positive, reinforcing the Altra Score's upgrade to a bullish regime. This combination of indicators points to a rebuilding of momentum after a period of bearish sentiment.
Edwards Lifesciences (EW)
Edwards Lifesciences, a leader in heart valve therapies, demonstrated an even more pronounced momentum surge, with its Altra Score rocketing from 54.5 (Neutral) to 90.9 (Strong Bullish) on August 3, 2026. A score of 90.9 places EW firmly in the 'Strong Bullish' category, indicating robust multi-timeframe momentum. The stock is trading above its key EMAs, underscoring its upward trajectory. The bullish Weekly EMA Crossover, which occurred on April 24, 2026, provided an earlier signal of this strengthening trend. All of EW's RSI readings across daily (55.82), weekly (55.36), and monthly (62.66) timeframes are well above the 50 mark, signifying healthy and sustained buying pressure. This comprehensive strength across EMAs and RSI suggests Edwards Lifesciences is experiencing strong positive momentum within the Healthcare sector.
Gilead Sciences (GILD)
Gilead Sciences, a biopharmaceutical company, also saw its Altra Score shift significantly on August 3, 2026, climbing from 39.7 (Bearish) to 72.0 (Bullish). This move indicates a clear transition from a bearish momentum regime to a bullish one. GILD's price is now situated above its key EMAs, aligning with the positive score change. A more recent bullish Weekly EMA Crossover, dated July 28, 2026, provides timely confirmation of the stock's improving technical posture. The stock's daily RSI is at 50.42, with weekly at 50.1, and monthly at 58.42, all hovering around or above the 50 level. This suggests that the stock is gaining upward traction and overcoming prior bearish pressures, making it another name to watch as the Healthcare sector continues to exhibit leadership and accelerating momentum.
What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.
Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.
Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.